Background. There has been discussion regarding the psychologic functioning of living donors who donate their kidney to an unrelated and unknown patient (''unspecified living donors''). This is the first prospective study to investigate group-and individual-level changes in psychologic functioning among a large group of unspecified donors. Methods. Forty-nine medically and psychologically screened unspecified living kidney donors completed the Symptom Checklist before and after donation. Results. Group-level analysis showed that overall psychologic symptoms increased after donation (P=0.007); the means remained within the average range of the normal population. Individual-level analysis showed that 33 donors showed no statistically significant change, 3 donors showed a statistically significant decrease, and 13 donors showed a statistically significant increase in psychologic symptoms. Two of the latter donors showed a clinically significant increase. Conclusions. We found more increases in psychologic symptoms than decreases, particularly if follow-up time was longer. However, for almost all donors, these increases were not clinically significant and the clinically significant changes found are comparable with natural fluctuations in psychologic symptoms in the general population. Possibly, the donors underreported their psychologic symptoms before donation to pass the screening. Due to the low level of predonation symptoms reported, regression to the mean could also explain the results. Although we found that changes were not associated with donation-related factors, it is possible that other donation-related factors or other life events not measured have an influence on psychologic functioning. Therefore, further research is needed to investigate whether the fluctuations are related to the donation process.
O ver the past decade, an increasing number of individuals have donated their kidney to an unknown recipient with whom they are not genetically related or emotionally bonded (1) . This type of donor is classified as an ''unspecified donor'' and has previously been referred to as an altruistic, anonymous, Good Samaritan, or living unrelated donor (2) . This procedure is performed in only a limited number of countries (3) and the number of these donations is relatively small in comparison with specified donations (1) . Within the transplant community, there has been debate regarding the psychologic functioning of unspecified donors (4, 5) . Some professionals questioned whether the motivations of these donors (e.g., ''to help an unknown person without direct benefit'') were a sign of psychologic dysfunction (4, 6) . A study by Henderson et al. (4) revealed that a significant number of the individuals who were interested in unspecified donation were psychologically stable. However, we know little about whether the donation has an influence on the psychologic functioning of the donors. To gain more insight into this question, it is important to investigate the psychologic functioning of unspecified donors before and after donation.
Until now, a limited number of studies have investigated psychologic outcomes of unspecified living kidney donors after donation (7Y10). These studies concluded that most donors reported no psychologic problems after donation, although a few donors reported unexpected stress or that the donation contributed to depression or anxiety (7, 8, 10) .
A study by Massey et al. investigated the psychologic functioning of the first 24 unspecified living kidney donors in their center using a pre-post design (9) . The results of this study showed few group-level changes in psychologic symptoms after living kidney donation. Although this study reported on one of the largest groups of unspecified donors at that time, the sample size was relatively small for statistical analysis. In addition, a few individuals who donated to a known recipient with whom they had no previous genetic or emotional relationship were included and group-level analyses were used rather than individual-level analyses.
Building upon this previous study (9) , we performed a prospective study to investigate group-and individual-level changes in psychologic functioning among unspecified living kidney donors. We used the method of ''clinical significant change'' described by Jacobson and Truax (11) to investigate individual-level changes. Although the grouplevel analysis describes whether the means of the pretest and posttest statistically differ from each other, the clinical significant change method provides information about the variability in changes from person to person and whether these changes are clinically relevant. Further, we included only unspecified donors in the analysis: therefore, the present research population is a homogenous group of unsolicited, unspecified living kidney donors. Finally, we investigated whether sociodemographic characteristics, procedural characteristics of the donation, and self-reported experiences of the donation were associated with changes in psychologic functioning.
RESULTS

Sociodemographic Characteristics
Forty-nine unspecified donors completed the Symptom Checklist (SCL-90) before (median, 9; range, 2Y13 months) and after (median, 19; range, 3Y36 months) their donation. Table 1 shows the sociodemographic characteristics of the participants. Age at donation ranged between 31 and 84 years (median, 59 years). The participants were all Caucasians, except for one; more than half of the participants were male, in paid employment, well educated, religious, married or living together, and a parent.
Psychologic Symptoms
Twenty-five donors completed the self-reported questionnaire SCL-90 via the telephone and 24 donors completed the questionnaire at the outpatient clinic. Postdonation psychologic symptoms did not differ according to method of completion (t(47)=j0.52; P=0.61). Table 2 gives an overview of the means and standard deviations (SD) of the predonation, postdonation, and difference scores. A higher score on the SCL-90 refers to a greater number of symptoms and thus lower psychologic functioning. These mean scores were compared with the Dutch norm scores of the general population (12) . Table 2 shows that the means of the predonation and postdonation total and subscales fall into the average range for the general Dutch population, with the exception of the mean of ''sleep problems'', which falls into the high range after donation.
Group-Level Analyses
Paired t tests revealed significantly higher postdonation scores than predonation scores for the total score (psychoneuroticism) and the subscales: anxiety, depression, somatization, hostility, and sleep problems (see Table 2 ). Agoraphobia, inadequacy in thought and action, and interpersonal sensitivity did not significantly change.
Individual-Level Analyses
Figures 1 and 2 show the classification of the predonation and postdonation scores of the participants based on the two criteria of clinical significant change.
All individuals in sections A to D had a predonation score that fell into the functional range (n=45). The individuals in section A showed a statistically significant decrease in symptoms (n=3). The individuals in section B showed no statistically significant change and were thus ''unchanged'' (n=30). The individuals in section C showed a statistically significant increase in psychologic symptoms; however, their postdonation score remained in the functional range and was thus not clinically significant (n=10). The individuals in section D also showed a statistically significant increase and their postdonation score shifts to the dysfunctional range and was thus clinically significant (n=2).
All individuals in sections E to G had a predonation score that fell into the dysfunctional range (n=4). There are no individuals in section E, which shows a clinically significant decrease in symptoms. The individuals in section F showed no statistically significant change and were thus ''unchanged'' (n=3). The individual in section G showed a statistically significant increase in symptoms (n=1).
Factors Associated With Change in Psychologic Symptoms
Association With Sociodemographic Characteristics, Procedural Characteristics, and Self-Reported Experiences of the Donation
The following factors that had a potential predictive relationship with psychoneuroticism difference scores were entered into the model (PG0.15): time since donation, whether donation fulfilled one's expectations, and marital status. The final model retained time (predonation vs. postdonation) and ''time since donation'' and their interaction as covariates (Table 3) . We centered ''time since donation'' to facilitate the interpretation. This model implies that participants with a mean time since donation (19.3 months) had a predonation psychoneurotic estimation of 112.6 and a postdonation score of 119.5 (d=0.30, a small effect). Participants who had a year longer time since donation had about the same predonation score, but their postdonation score was estimated at 124.6 (d=0.53, a medium effect). Participants with a year shorter time since donation (i.e., 7 months) had a marginal increase in psychoneuroticism score (114.2; d=0.07).
DISCUSSION
In the present study, we investigated both group-and individual-level changes in psychologic functioning among unspecified living kidney donors between predonation and postdonation. We note that the sample size is relatively small; however, because unspecified donation is not a common procedure, we describe the psychologic functioning of the largest group of unspecified donors to our knowledge. On a group level, we found an increase in overall psychologic symptoms, anxiety, depressive symptoms, somatization, hostility, and sleep problems between predonation and postdonation. However, the means of these scales remained within the average range compared with Dutch norm scores after donation, with the exception of sleep problems. These findings are consistent with the study of Massey et al. (9) . On an individual level, most donors (n=33) showed no statistically significant change, whereas a minority showed a statistically significant FIGURE 1. Scatter plot of distribution total scores. AYD, predonation score in the functional range. A, statistical significant decrease. B, no statistically significant change. C, statistically significant increase but not clinically significant. D, statistically and clinically significant increase. EYG, pre-donation score in the dysfunctional range. E, statistically and clinically significant decrease. F, no statistically significant change. G, statistically significant increase.
* 2013 Lippincott Williams & Wilkins decrease (n=3) or increase (n=13) in psychologic symptoms. However, 2 of those 13 donors showed a clinically significant increase. This number corresponds with the percentage of donors who reported that being a donor contributed to anxiety or depression in the earlier mentioned study of Rodrigue et al. (10) . Also, among specified donors, most studies reveal that a small percentage of the donors show an increase in psychologic symptoms, although the results are, to some extent, conflicting (13) . Our results highlight the importance of long-term psychologic follow-up of unspecified living kidney donors and psychosocial support upon indication. A subsequent question is whether the fluctuations found are attributable to the donation process.
A first consideration is that the predonation measurement was part of the psychosocial screening. It is plausible that some donors underreport their psychologic symptoms before donation to pass the screening. A study by Hurst et al. (14) also indicated that living kidney donors have the tendency to respond in a socially desirable manner and try to appear psychologically healthy during a psychologic evaluation before the donation. Repressed predonation scores could account for the change in symptoms over time.
A second consideration is that, as a consequence of the low level of symptoms reported before donation, ''regression to the mean'' could explain the results. Regression to the mean refers to the phenomenon that, in the case of an extreme score on a first measurement, the score will tend to be closer to the mean on the second measurement (15) . The donors successfully passed the screening partly because they had low scores on the SCL-90 (Figure 1 shows that the predonation scores are relatively low). Subsequently, the chance of scores closer to the mean at the second measurement point is greater than the chance of the same extreme scores. Similarly, because most donors had a predonation score in the functional range, it was not possible to show a clinically significant decrease in psychologic symptoms, and it was only possible to remain stable or increase.
A third consideration is the question whether the two cases of clinically significant increase in psychologic symptoms are comparable with observed variation in psychologic symptoms in the general population. The incidence rate of first onset of any mental disorder in the general population is 5.7 per 100 person-years at risk in The Netherlands (16) and 6.6 per 100 person-years at risk in the United States (17) . In our study, we found that 4% shifted from a functional to a dysfunctional range in a median time of 26 months (range, 6Y46 months). Comparing this percentage with the incidence rates in the general population, the fluctuations found in our study appear to be comparable with natural fluctuations in psychologic symptoms in the general population. We note that the SCL-90 gives an indication of the level of psychologic symptoms and is not a tool for making a clinical diagnosis. Nevertheless, the SCL-90 does successfully discriminate between psychiatric patients and healthy individuals (18) . A fourth consideration is that more time after donation was correlated with a larger increase in psychologic symptoms. This association could have different explanations. First, it is possible that donors experience a boost in self-esteem and life satisfaction as result of feelings of pride and positive reactions from the environment right after donation. This was also found in the study by Rodrigue et al. (10) . This boost could suppress or outweigh psychologic symptoms in the first months after donation. However, these positive effects might diminish over time, through which psychologic symptoms come to the fore. A second possible explanation is that the fluctuations are not related to the donation process but are affected by other life events in the intervening time. The data of this current study cannot clarify whether one of the explanations is true, because we did not register other life events during the research period and time between donation and postdonation measurement varied per donor.
A final consideration is that if the changes in psychologic symptoms were associated with the donation, one would expect that donors with a less positive experience of the donation (e.g., who experienced a minor medical complication) would show a greater increase in psychologic symptoms. Because we did not find associations between change in psychologic functioning and procedural characteristics of the donation and self-reported experiences of the donation, this suggests that the fluctuations in psychologic symptoms are independent of the donation. However, it is possible that other donation-related factors not measured in this study (e.g., pain) have an influence on psychologic functioning.
To get more insight into the question whether the fluctuations in psychologic functioning are attributable to the donation process, prospective cohort studies are needed in which psychologic functioning is measured at several and consistent time intervals for every donor and comparisons could be made with the changes in psychologic functioning of specified donors. Multicenter or international studies would allow greater generalizability of the results. Other life events and other donation-related factors (e.g., pain and expectations regarding the donation) not measured in this study should be taken into account. In addition, positive aspects of mental health (e.g., self-confidence) should be measured to evaluate the potential occurrence of a boost in mental health after donation.
In conclusion, we found fluctuations in psychologic symptoms over time that were more often increases than decreases, particularly if the time since donation was larger. However, for almost all donors, these increases were not clinically significant and the clinically significant changes found are comparable with natural fluctuations in psychologic symptoms in the general population. Repressed predonation scores as consequence of underreporting before donation and regression to the mean might have contributed to the change in symptoms over time. Based on the current data, it remains unclear whether the fluctuations are attributable to the donation process or not; therefore, further research is needed. Additionally, the results of this study highlight the importance of long-term psychosocial follow-up of unspecified living kidney donors and psychosocial support upon indication.
MATERIALS AND METHODS
Participants
Between April 2000 and October 2011, 70 unspecified donors donated their kidney in the Erasmus Medical Center (Rotterdam, The Netherlands) and were invited to participate in the study. One donor did not wish to participate. Thirteen donors without a predonation measurement were excluded from the analysis. Of the remaining 56 donors, 7 donors were already patients themselves before donation: 2 donors had a medical indication for nephrectomy and 5 donors had a chronic disease (2 patients with Huntington's disease, 1 with ependymoma, 1 with oligodendroglioma, and 1 with progressive chronic obstructive pulmonary disease). These donors were excluded from the analyses, because their physical symptoms and the disease progression may influence their psychologic functioning. The 49 remaining donors were included in the analyses.
Procedure
In addition to the standard medical and psychosocial screening for every living kidney donor (19) , prospective unspecified donors have a consultation with a clinical psychologist (R.E.). In an in-depth interview, he explores the risk of potential psychologic harm to the donor. The interview covers the following topics: motives, voluntariness, expectations, psychiatric background, emotional resilience, understanding of the associated risks, perception of reality, earlier hospital experience, anticipated regret and, practical and emotional social support. Furthermore, the potential donor completes the SCL-90 using a pen-and-paper test (see Measurements). The predonation SCL-90 measurement was used as the baseline in the current study.
After donation, the SCL-90 was administered by a psychologist (L.T.) via the telephone or completed by the donor at the outpatient clinic.
Measurements
Sociodemographic Characteristics
The following sociodemographic characteristics were obtained from medical records: age (years), gender, ethnicity, employment status, marital status, highest level of education completed, number of children, religious affiliation, and whether the person was registered in the Dutch organ donation register. See Table 1 for details.
Psychologic Functioning
The Dutch version of the SCL-90 (12) was used to measure psychologic functioning. The SCL-90 consists of 90 items that measure self-reported psychologic symptoms of the past 2 weeks. Each item is rated on a fivepoint Likert scale ranging from ''not at all'' to ''extremely''. The total score of the questionnaire (psychoneuroticism) gives an indication of current general psychologic functioning (potential range, 90Y450). A higher score indicates greater psychologic symptoms. The SCL-90 also comprises eight subscales: agoraphobia, anxiety, depression, somatization, inadequacy in thought and action, interpersonal sensitivity, hostility, and sleep problems. Scores for each subscale were summed.
The internal consistency (Cronbach's >) for the total score is 0.97 for the general Dutch population, which represents excellent reliability. The internal consistency of the eight subscales varies between good and excellent (>=0.76Y0.91). Because of the high reliability the SCL-90 can be used to draw conclusions on an individual level and it is a valid instrument to distinguish between the normal population and psychiatric populations (12) .
Procedural Characteristics and Experiences of the Donation
The following procedural characteristics of the donation were obtained from medical records: type of donation (donation directly to a person on the waitlist or a domino-paired procedure (20) and length of hospital admission (days) and the occurrence of minor medical complications (e.g., wound infection) within 3 months after donation (yes/no). None of the donors experienced a major complication. At Erasmus Medical Center, unspecified donors are asked if they want to donate in a dominopaired procedure or directly to the waitlist. Time between the date of donation and postdonation measurement (months) was recorded as ''time since donation'' .
Self-reported physical health before donation (1=very bad and 10=very good) was obtained from a self-constructed questionnaire that was administered by the transplantation coordinator before donation. Finally, the following self-reported experiences of the donation were obtained from self-reported questionnaires that were administered by the transplant coordinator 3 months after donation: physical health (1=very bad and 10=very good), whether donation fulfilled one's expectations (1=disappointed and 10=exceeded one's expectations), and after how many weeks the donor felt completely recovered. The administration of these self-constructed questionnaires is part of standard procedure for donors at Erasmus Medical Center.
Statistical Analyses
First, we computed the averages of the predonation and postdonation SCL-90 total scale and the subscales. These averages were compared with the norm scores of the Dutch general population, which are classified into seven categories ranging from very low to very high psychologic symptoms. Paired t tests were carried out to examine whether the predonation and postdonation means differed.
Second, to investigate the individual-level changes in psychoneuroticism, we used the method of ''clinical significant change'' (11). To our knowledge, this is the most appropriate method to describe individual changes in psychologic symptoms. We used the method as described in the Dutch manual of the shortened version of the SCL-90, the Brief Symptom Inventory (21) .
The method of ''clinical significant change'' consists of two criteria. The first criterion is statistical significance, which is measured using the Reliable Change Index (RCI). Using the RCI, one can determine whether an individual change in symptoms is more than one can expect based on measurement error. An individual change is considered to be statistically significant if the individual change exceeds the RCI. We calculated the RCI for the psychoneuroticism score with the RCI formula described by Jacobson and Truax (11) . We used the internal consistency (Cronbach's >=0.97) and the SDs of the general Dutch population (SD=32.38) and the outpatient psychiatric patients (SD=61.60) that are described in the Dutch manual of the SCL-90 (12) . These calculations result in a RCI=16 for the functional range and RCI=30 for the dysfunctional range.
The second criterion is clinical significance, a cutoff point between the functional and the dysfunctional range. We calculated this cutoff point for the psychoneuroticism score with the c-formula reported by Jacobson and Truax (11) . We used the Dutch general population norms (mean=118.28, SD=32.38) and the outpatient psychiatric patients norms (mean=203.55, SD=61.60) (12) , resulting in a cutoff point of C=148. All participants with a score lower than the cutoff point were categorized in the functional range, and all participants with a score above this point in the dysfunctional range. A statistically significant change is a requirement for a clinically significant change (22) .
The third question is whether sociodemographic characteristics, procedural characteristics, and self-reported experiences of the donation were related to changes in the psychoneuroticism score. Univariate analyses (correlation for continuous variables and independent t tests for the categorical variables) were carried out to select the predictors that had a potential relationship with psychoneuroticism difference scores (PG0.15). Subsequently, we carried out a saturated multilevel regression with time (predonation vs. postdonation), these predictors, and their interactions with time as covariates. Using Wald tests, nonsignificant covariates were removed step by step until a parsimonious model was reached. Cohen's d was calculated for the difference between pre-and post-test estimates.
